T80.411 Rh incompatibility with delayed hemolytic transfusion reaction

Name of the Condition

• Rh incompatibility with delayed hemolytic transfusion reaction.

Summary

This condition describes an immune-mediated hemolytic reaction occurring when Rh-negative individuals receive Rh-positive blood or blood products, leading to delayed destruction of red blood cells (hemolysis). It results from the recipient’s immune system recognizing Rh antigens as foreign, triggering antibody production and subsequent hemolysis. The reaction is delayed, with symptoms typically appearing days to weeks after transfusion.

Causes

The reaction is triggered by the presence of Rh-positive red blood cells in an Rh-negative recipient, which the immune system identifies as foreign. This initiates antibody production, causing hemolysis. Transfusions of whole blood, packed red blood cells, or plasma products containing Rh-positive cells are common sources. The delayed nature indicates a slower immune response compared to acute reactions.

Risk Factors

• Rh-negative blood type
• Prior exposure to Rh-positive blood (e.g., previous transfusions or pregnancy)
• Inadequate crossmatching or typing before transfusion
• Use of blood products with unknown Rh status

Symptoms

• Fever, chills, or rigors
• Jaundice or dark urine (hemoglobinuria)
• Anemia-related fatigue or pallor
• Shortness of breath or tachycardia
• Abdominal or back pain
• Elevated bilirubin levels (laboratory finding)

Diagnosis

Diagnosis involves confirming Rh incompatibility through blood typing and crossmatching, along with clinical assessment of transfusion history and timing of symptom onset. Laboratory tests may include direct antiglobulin testing (Coombs test) and reticulocyte counts to evaluate hemolysis.

Treatment Options

Treatment focuses on managing hemolysis and preventing further complications. This may include discontinuing the transfusion, supportive care (e.g., hydration, monitoring for renal function), and addressing anemia if severe. In some cases, additional transfusions with Rh-negative blood may be necessary.

Prognosis and Follow-Up

Prognosis is generally favorable with prompt recognition and treatment. Most patients recover without long-term sequelae, but follow-up may be required to monitor for delayed complications or recurrent reactions. Close observation of renal function and hemoglobin levels is recommended.

Complications

• Acute kidney injury due to hemoglobinuria
• Severe anemia requiring additional transfusions
• Rarely, disseminated intravascular coagulation (DIC) or shock in severe cases

Lifestyle & Prevention

Prevention involves rigorous blood typing and crossmatching before transfusions to avoid Rh-incompatible products. Patients with a history of Rh incompatibility should be informed of their blood type and the importance of disclosing this information during future medical encounters.

When to Seek Professional Help

Seek immediate medical attention if symptoms such as fever, chills, jaundice, or dark urine occur after a blood transfusion, especially if they develop days to weeks later. Early intervention can prevent severe complications.

Tips for Medical Coders

Document the timing of symptom onset relative to the transfusion (delayed, typically >24 hours) and confirm Rh incompatibility through laboratory results. Ensure the transfusion history and clinical findings support the diagnosis. Code T80.411 is specific to delayed hemolytic reactions; avoid using it for acute or unspecified timing.